SCHRECK THOMAS A 4
4 · ACELRX PHARMACEUTICALS INC · Filed Feb 18, 2011
Insider Transaction Report
Form 4
SCHRECK THOMAS A
Director
Transactions
- Conversion
Common Stock
2011-02-16+41,800→ 41,800 total - Conversion
Common Stock
2011-02-16+13,932→ 13,932 total(indirect: See Footnote) - Conversion
Series A Convertible Preferred Stock
2011-02-16−30,605→ 0 total→ Common Stock (41,800 underlying) - Conversion
Series A Convertible Preferred Stock
2011-02-16−10,201→ 0 total(indirect: See Footnote)→ Common Stock (13,932 underlying)
Footnotes (5)
- [F1]The shares reflect the automatic conversion of 30,605 shares of the Issuer's Series A Preferred Stock for 41,800 shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering.
- [F2]The shares reflect the automatic conversion of 10,201 shares of the Issuer's Series A Preferred Stock for 13,932 shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering.
- [F3]The shares are held in trust for Mr. Schreck's children. Mr. Schreck disclaims beneficial ownership of the shares.
- [F4]Immediately convertible into shares of the Issuer's common stock.
- [F5]These shares have no expiration date.